Waseem AlZamzami | Medicine and Dentistry | Best Researcher Award

Assoc. Prof. Dr. Waseem AlZamzami | Medicine and Dentistry | Best Researcher Award

University of Tabuk, Saudi Arabia

Assoc. Prof. Dr. Waseem A. AlZamzami is an accomplished researcher and academic in hematopathology, molecular hematology, and cancer biology, with a strong focus on genomics, transcriptomics, metabolomics, and bioinformatics. He earned his Ph.D. in Clinical Laboratory Science from The Catholic University of America, Washington DC (2015–2022), following an M.S. in Health Sciences from Quinnipiac University, Connecticut (2013–2015), and a B.Sc. in Laboratory Medicine from Umm Al-Qurra University, Saudi Arabia (2002–2006). His professional journey includes extensive research training at the National Cancer Institute/National Institutes of Health (NCI/NIH), Bethesda, USA, where he contributed to advancing cancer genetics and translational hematology. Currently serving as an Assistant Professor of Hematology at the University of Tabuk, Saudi Arabia, he has held multiple leadership roles such as Committee Chairman for Laboratory Management, Unit Chairman for Measurement and Evaluation, and active member of Accreditation, Quality Assurance, and Curriculum Development committees. His research interests center on genetic screening, biomarker discovery, and integration of multi-omics to drive precision oncology and personalized treatment strategies. Dr. AlZamzami has authored publications in reputed journals including Discovery Medicine, Molecular Syndromology, PLOS ONE, and Cancers, with a Scopus record of 9 documents, 36 citations, and an h-index of 3, alongside three recent Saudi patents in hematological malignancies and cancer genomics. He is also a dedicated reviewer for journals such as PLOS ONE, Process Biochemistry, and International Immunopharmacology. His research skills span molecular diagnostics, bioinformatics, laboratory medicine, multi-omics analysis, and translational applications bridging bench to bedside. Recognized through international symposium presentations at NIH and national scientific forums, he has also contributed to scientific community development by mentoring students and organizing academic events. In conclusion, Dr. Waseem A. AlZamzami exemplifies a distinguished researcher whose academic excellence, innovative research, and leadership contributions to cancer biology and hematology strongly position him as a driving force in advancing precision medicine and biomedical research globally.

Profile: Scopus |ORCID| Google Scholar

Featured Publications

  1. Yan, H., Malik, N., Kim, Y. I., He, Y., Li, M., Dubois, W., Liu, H., Peat, T. J., Nguyen, J. T., … (2021). Fatty acid oxidation is required for embryonic stem cell survival during metabolic stress. EMBO Reports, 22(6), e52122.

  2. Oyouni, A. A. A., Al-Amer, O. M., Ali, F. A. Z., Altayar, M. A., Jalal, M. M., Albalawi, R. S. M., … (2022). Melatonin ameliorates the adrenal and pancreatic alterations in streptozotocin-induced diabetic rats: Clinical, biochemical, and descriptive histopathological studies. Frontiers in Veterinary Science, 9, 1016312.

  3. Seshadri, V. D., Oyouni, A. A. A., Hawsawi, Y. M., Aljohani, S. A. S., Al-Amer, O. M., … (2022). Chemopreventive role of Tin oxide–Chitosan–Polyethylene glycol–Crocin nanocomposites against lung cancer: An in vitro and in vivo approach. Process Biochemistry, 120, 186–194.

  4. Al-Amer, O. M., Mir, R., Hamadi, A., Alasseiri, M. I., Altayar, M. A., AlZamzami, W., … (2023). Antiapoptotic gene genotype and allele variations and the risk of lymphoma. Cancers, 15(4), 1012.

  5. Vijayaragavan, P., Rathi, M. A., Gopalakrishnan, V. K., Pashameah, R. A., … (2022). CpG methylation analysis of tumour suppressor gene and expression of cathepsin B in renal cell carcinoma. Journal of King Saud University – Science, 34(8), 102330.

Emmanuel Chona | Health Professions | Young Researcher Award

Mr. Emmanuel Chona | Health Professions | Young Researcher Award

Muhimbili University of Health and Allied Sciences, Tanzania

Mr. Emmanuel Z. Chona is a registered nurse, young research scientist, and academic professional with a strong foundation in nursing, public health, and implementation science. He earned his Bachelor of Science in Nursing from the Muhimbili University of Health and Allied Sciences (MUHAS) and is currently pursuing a Master of Public Health in Implementation Science at the same institution under the prestigious EMPOWER-TZ Scholarship by Johns Hopkins University Bloomberg School of Public Health. His professional experience includes serving as an Intern Nurse at Tumbi Regional Referral Hospital, where he gained comprehensive clinical skills in patient care, emergency procedures, and health education, and working as a Tutorial Assistant at St. Joseph University in Tanzania and later at MUHAS, contributing actively to teaching, research, consultancy, and curriculum development. His research interests span oncology nursing, diabetes management, chronic disease care, public health challenges, and disaster preparedness, demonstrated through his 12 peer-reviewed publications (5 as first author) in reputable journals such as PLoS One, BMC Women’s Health, Psycho-Oncology, and Public Health Challenges, with over 202 citations and an h-index of 7, showcasing his scholarly impact. He possesses strong research and technical skills in SPSS, STATA, and NVivo, along with expertise in teaching methodology, communication, and teamwork. His career achievements have been recognized through awards such as the Early Career Research Grant from the Tanzania Diabetes Association, an Excellence Performance Certificate for best undergraduate performance at MUHAS, and the EMPOWER-TZ Master’s Scholarship. Beyond academia, he is actively engaged in professional and community service as a member of the Tanzania National Nurses Association, the International Society of Substance Use Professionals (ISSUP), and a volunteer with the Tanzania Red Cross Society. In conclusion, Emmanuel Chona is an emerging leader in public health and nursing research, combining academic excellence, clinical practice, and impactful research with community service, and he demonstrates strong potential to advance healthcare delivery, mentor future health professionals, and contribute meaningfully to science and society on both national and global scales.

Profile: Scopus | ORCID

Featured Publications

Chona, E. Z., Gosse, R. A., Msengi, E. A., Aruldhas, T. P., Mkonongo, L., Matle, T. M., Iseselo, M. K., & Ambikile, J. S. (2025). Life experiences of women diagnosed with cervical cancer in Sub‐Saharan Africa: A systematic review of qualitative studies. Psycho‐Oncology, 34(1), e70280.

Chona, E. Z., Gosse, R. A., William, D. A., Kiang, R. H., & Ramadham, F. B. (2025). Dietary knowledge and practices among diabetes patients attending Muhimbili National Hospital in Dar es Salaam, Tanzania. Tanzania Journal of Health Research, 26(4), 1–10.

Chona, E. Z., Kayange, L. F., & Iseselo, M. K. (2024b). Factors associated with satisfaction with diabetes care among patients attending public diabetic clinics in Dar es Salaam, Tanzania: A cross-sectional study. Public Health Challenges, 3(3), 1–8.

Chona, E. Z., Kayange, L. F., & Iseselo, M. K. (2024a). Barriers and facilitators to satisfaction with diabetes care: The perspectives of patients attending public diabetic clinics in Dar es Salaam, Tanzania. PLoS One, 19(5), e0302858.

Chona, E. Z., Msengi, E. A., Gosse, R. A., & Ambikile, J. S. (2023). The lived experiences and caring needs of women diagnosed with cervical cancer: A qualitative study in Dar es Salaam, Tanzania. PLoS One, 18(1), e0289925.

Ankit Agrawal | Health Professions | Best Researcher Award

Assist. Prof. Dr. Ankit Agrawal | Health Professions | Best Researcher Award

Post Graduate Institute of Child Health, India

Assist. Prof. Dr. Ankit Agrawal is an accomplished clinician and researcher in Pediatric Gastroenterology and Hepatology with a distinguished academic and professional trajectory marked by consistent excellence and leadership. He completed his MBBS at Peoples College of Medical Science and Research Centre, Bhopal, followed by an MD in Pediatrics  from Gajra-Raja Medical College, Gwalior, and a DM in Pediatric Gastroenterology from Sanjay Gandhi Postgraduate Institute of Medical Sciences (SGPGIMS), Lucknow. He began his academic career as Assistant Professor at SGPGIMS and is currently serving as Assistant Professor in the Department of Pediatric Gastroenterology at Post Graduate Institute of Child Health, Delhi-NCR, Noida, where he integrates patient care, teaching, and research. His research interests encompass chronic pancreatitis, portal hypertension, pediatric liver diseases, and sustainable innovations in pediatric endoscopy, with a growing body of publications in reputed journals such as Pancreatology, Journal of Clinical and Experimental Hepatology, and Clinical and Experimental Pediatrics, along with contributions to academic books and clinical guidelines. Dr. Agrawal has developed extensive research skills in pediatric endoscopy, including diagnostic UGI endoscopy, colonoscopy, endoscopic band ligation, sclerotherapy, dilatations, polypectomy, and advanced interventional procedures, complemented by training in pediatric hepatology, metabolic liver diseases, and radiological interventions. His academic record includes 111 research documents, 402 citations, and an h-index of 10, reflecting his increasing impact in the field. Recognized internationally, he has received awards such as the First Prize for Best Poster at the Indian Society of Gastroenterology (ISG) Annual Conference (Jaipur, 2023) and the Young Investigator Award for oral presentations at the European Society of Pediatric Gastroenterology, Hepatology, and Nutrition (ESPGHAN, Milan, 2024) and ISG Annual Conference (Varanasi, 2024). With strong professional expertise, collaborative research experience, and a commitment to child health, Dr. Agrawal exemplifies excellence in both academia and clinical practice. His future research and leadership potential lie in advancing global collaborations, increasing high-impact publications, and developing innovative approaches that elevate pediatric gastroenterology standards worldwide, making him highly deserving of recognition for his contributions to research and society.

Profile: Scopus

Featured Publications

Agrawal, A., Gaur, A., & Ambey, R. (2020). Neonatal mid upper arm circumference as surrogate of birth weight. International Journal of Contemporary Pediatrics, 7(3), 491–494.

Agrawal, A., Gaur, A., & Ambey, R. (2020). Newborn mid-upper arm circumference as valid proxy marker of gestational age. Indian Journal of Child Health, 7(2), 54–56.

Agrawal, A. (2024). Urgent need for “green endoscopy” in routine practice in India. Annals of Pediatric Gastroenterology and Hepatology (ISPGHAN).

Agrawal, A., Srivastava, A., Mishra, P., Malik, R., Agrawal, V., Raj, A., Sarma, M. S., Poddar, U., & Bhat, N. K. (2024). Quality of life is impaired in children with chronic pancreatitis: A multicenter study. Pancreatology, 24(6), 817–826.

Agrawal, A., & Sen Sarma, M. (2025). Vomiting: Causes, approach, and cyclical vomiting. In I. Gupta (Ed.), Learning through MCQ in Pediatrics. New Delhi: Jaypee Brothers Medical Publishers Pvt Ltd.

Agrawal, A., Srivastava, A., Moirangthem, A., Singh, S. M., Kodethoor, D., Vadlapudi, S. S., Sarma, M. S., & Poddar, U. (2025). Glycerol-3-Phosphate dehydrogenase 1 deficiency and steatotic liver disease in children: Our cases and review of literature. Journal of Clinical and Experimental Hepatology, 15(3), 102484.

Agrawal, A. (2025). Drugs in pediatric gastroenterology. Annals of Pediatric Gastroenterology and Hepatology, 6(4).

Giovanni Musso | Medicine and Dentistry | Best Researcher Award

Giovanni Musso | Medicine and Dentistry | Best Researcher Award

AOU San Luigi Gonzaga Orbassano (Torino), Italy

Dr. Giovanni Musso is a renowned clinician and researcher in Internal Medicine with a distinguished academic and professional career. He graduated in Medicine in 1996 with top honors (110/110) and completed his specialization in Internal Medicine in 2002 with distinction. Currently serving at the Department of Internal Medicine, Humanitas Gradenigo Hospital, Turin, he has devoted his career to the study of lipid and glucose metabolism, with particular emphasis on non-alcoholic fatty liver disease (NAFLD), metabolic dysfunction-associated steatotic liver disease (MASLD/MASH), and related metabolic complications. He leads international collaborative research involving 34 centers worldwide, producing high-impact findings on NAFLD epidemiology, pathogenesis, and staging, with publications in PLOS Medicine, Hepatology, Gastroenterology, BMJ, and other leading journals. His research interests include lipidomics, postprandial metabolism, gut microbiota, metabolic inflammation, and therapeutic innovations such as curcumin-based interventions and endoscopic approaches for metabolic disorders. His research skills span clinical trials, meta-analyses, translational studies, and consensus guideline development. Recognized globally, Dr. Musso has authored 101 documents, accrued 12,017 citations, and holds an impressive h-index of 49 (Sept 2025). His honors include co-authoring international consensus statements and leading global research collaborations. With his proven excellence in research, teaching, and clinical innovation, Dr. Musso continues to advance the field of hepatology and metabolic medicine while shaping future directions in precision healthcare.

Profile: ScopusORCID

Featured Publications

  • Musso, G., Mariano, F., Mella, A., Pinach, S., & Gambino, R. (2025, August 7). Meal-Induced NF-κB Activation in Mononuclear Cells Triggers Lumican Secretion and Promotes Chronic Kidney Disease in Metabolic Dysfunction-Associated Steatotic Liver Disease. MedComm, 6(8), e70122.

  • Carpenito, N., Leporati, M., Sciarrillo, A., Pensa, A., Gambino, R., Musso, G., Mella, A., Biancone, L., Risso, D., Mariano, F., & Cosseddu, D. (2025, May 16). LC-MS/MS Determination of Quorum Sensing Molecules in Plasma from Burn Patients with Septic Shock Sustained by Acinetobacter baumannii. Antibiotics (Basel), 14(5), 517.

  • Musso, G., Mella, A., Mariano, F., Cassader, M., De Michieli, F., Riva, A., Petrangolini, G., Togni, S., Pinach, S., & Gambino, R. (2024). Impaired Postprandial GLP-2 Response Enhances Endotoxemia, Systemic Inflammation, and Kidney Injury in Metabolic Dysfunction-Associated Steatohepatitis (MASH): Effect of Phospholipid Curcumin Meriva. Gut Microbes, 16(1), article 2424907.

  • Musso, G., Pinach, S., Mariano, F., Saba, F., De Michieli, F., Framarin, L., Berrutti, M., Paschetta, E., Parente, R., Lizet Castillo, Y., Leone, N., Castellino, F., Cassader, M., & Gambino, R. (2025, February 1). Effect of Phospholipid Curcumin Meriva® on Liver Histology and Kidney Disease in Nonalcoholic Steatohepatitis: A Randomized, Double-Blind, Placebo-Controlled Trial. Hepatology, 81(2), 560–575.

  • Musso, G., Pinach, S., Saba, F., De Michieli, F., Cassader, M., & Gambino, R. (2024, July). Endoscopic Duodenal Mucosa Ablation Techniques for Diabetes and Nonalcoholic Fatty Liver Disease

 

Xingwang Yao | Health Professions | Best Researcher Award

Assoc. Prof. Dr. Xingwang Yao | Health Professions | Best Researcher Award

The Second Xiangya Hospital (Central South University, China) | China

Dr. Yao Xingwang is a senior nurse and accomplished clinical researcher at the Operating Department, Xiangya Second Hospital, Central South University, China. With a strong background in clinical nursing, patient care, and interdisciplinary medical research, he has established himself as a leading figure in the integration of nursing practice with scientific innovation. His professional journey reflects dedication to enhancing the quality of healthcare services through advanced nursing strategies, patient-centered interventions, and translational research. Dr. Yao has actively contributed to the development of innovative treatment methods, clinical nursing guidelines, and healthcare technologies that improve patient outcomes in complex medical conditions. He has also played a key role in research projects funded by provincial and institutional bodies, focusing on areas such as cancer therapy, cardiovascular health, chronic disease management, and perioperative nursing care. Beyond clinical practice and research, Dr. Yao has contributed to academic literature through peer-reviewed journal articles, patents, and textbooks. His ability to bridge the gap between evidence-based nursing and real-world clinical application makes him a highly respected professional in his field. Dr. Yao’s leadership, innovation, and scholarly contributions position him as a distinguished candidate for recognition in international research awards.

Professional Profile

Education

Dr. Yao Xingwang pursued his academic journey at Central South University, one of China’s leading institutions in nursing education and medical sciences. He obtained a Bachelor of Science in Nursing, which laid the foundation for his clinical expertise and patient-centered approach in healthcare. Building upon this, he completed his Master of Science in Nursing under the supervision of esteemed faculty, where he deepened his understanding of advanced nursing practices, clinical interventions, and evidence-based care models. Throughout his education, Dr. Yao developed strong research skills, participating in academic projects that explored the intersections of nursing care and biomedical sciences. His postgraduate studies enabled him to contribute to multidisciplinary research teams, enriching his clinical knowledge with a solid research background. His academic foundation not only provided him with technical expertise but also instilled in him the values of professionalism, compassion, and scientific inquiry. This balance of clinical knowledge and academic training shaped him into a professional capable of leading complex nursing projects and conducting impactful clinical studies. His educational background has been the cornerstone of his career success, empowering him to blend theoretical knowledge with practical applications in the advancement of nursing science and patient care.

Professional Experience

Dr. Yao Xingwang has built an extensive professional career at the Operating Department, Xiangya Second Hospital, Central South University, where he has served in various capacities with increasing responsibility. His early experience as a clinical nurse provided him with hands-on expertise in perioperative care, surgical assistance, patient monitoring, and emergency response. Through dedication and continuous professional development, he advanced to the role of senior nurse, where he has been responsible for supervising clinical teams, ensuring adherence to nursing protocols, and implementing high standards of patient safety and care quality. In addition to his clinical responsibilities, Dr. Yao has been deeply engaged in medical research projects, serving as both a principal investigator and key member in studies supported by provincial foundations and health commissions. His professional experience extends to academic contributions, including publishing in high-impact journals and contributing to textbooks on nursing management and clinical practices. He has also been active in developing innovative healthcare devices, holding patents that address practical clinical challenges. Dr. Yao’s career reflects a seamless integration of nursing service, research innovation, and leadership, making him a role model for aspiring nursing professionals and a respected figure in the field of healthcare.

Research Interest

Dr. Yao Xingwang’s research interests lie at the intersection of nursing science, medical innovation, and patient-centered care. His work focuses on clinical nursing quality evaluation, mindfulness-based interventions for patients with chronic conditions, and the development of evidence-based nursing protocols to improve treatment outcomes. He has contributed significantly to research in cancer therapy, investigating the role of autophagy in cancer stem cell treatment and advancing photodynamic therapy strategies. In cardiovascular nursing, his studies have explored the mechanisms of myocardial injury and interventions that can reduce patient mortality and morbidity. Additionally, Dr. Yao has shown keen interest in mental health within nursing practice, leading projects that examine the impact of mindfulness therapy on depression, anxiety, and cognitive function in elderly diabetic patients. His research also extends to the development of clinical tools and devices, with patents addressing surgical and postoperative care needs. A common theme across his research is the integration of advanced biomedical insights with nursing interventions, ensuring that scientific advancements translate into tangible improvements in patient care. Dr. Yao’s research interests not only address pressing healthcare challenges but also reflect a vision of holistic, evidence-based nursing practice with global impact.

Research Skills

Dr. Yao Xingwang possesses a comprehensive set of research skills that complement his clinical expertise and enable him to conduct high-impact studies in nursing and healthcare. He is proficient in clinical trial design, data collection, and statistical analysis, allowing him to evaluate the effectiveness of nursing interventions with precision. His skills in laboratory techniques support his involvement in biomedical research projects, particularly in cancer biology and cardiovascular studies. Dr. Yao is experienced in the use of advanced imaging tools, including magnetic resonance imaging, for clinical research purposes. He is also skilled in qualitative and quantitative research methodologies, enabling him to address both patient experiences and measurable clinical outcomes. Beyond technical skills, Dr. Yao demonstrates strong project management capabilities, having successfully coordinated multidisciplinary research teams and contributed to projects funded by major provincial and institutional bodies. His ability to translate research findings into practical nursing protocols showcases his applied research strength. Furthermore, his editorial and textbook contributions reflect his academic writing and scientific communication skills. Collectively, these skills underscore his capacity to bridge clinical practice with rigorous research, positioning him as a versatile researcher dedicated to improving patient outcomes through evidence-based nursing innovations.

Awards and Honors

Dr. Yao Xingwang has earned recognition through his contributions to nursing research, clinical practice, and innovation. His scholarly achievements include publications in esteemed journals such as the International Journal of Molecular Medicine, FASEB Journal, and Medicine (Baltimore), where his work has advanced understanding in areas of degenerative disease, cancer biology, and clinical interventions. His role as co-first author and corresponding author in several papers highlights his leadership and intellectual contributions to collaborative research. Dr. Yao has also been honored for his innovation in healthcare technologies, holding utility model patents for devices such as adjustable pancreatic juice diversion systems, multifunctional operating bed covers, and specialized drainage devices for cardiac surgery. These patents demonstrate his ability to identify clinical challenges and provide practical, patient-focused solutions. Additionally, his editorial contributions as compiler and deputy editor of nursing and clinical surgery textbooks reflect recognition of his academic expertise and teaching value. These honors underscore his influence in shaping nursing knowledge, advancing clinical practice, and fostering healthcare innovation. Collectively, Dr. Yao’s awards and honors showcase a career defined by excellence, leadership, and impactful contributions to both academic research and clinical nursing practice.

Publication Top Notes

  • FOXO3-Activated circFGFBP1 Inhibits Extracellular Matrix Degradation and Nucleus Pulposus Cell Death via miR-9-5p/BMP2 Axis in Intervertebral Disc Degeneration In Vivo and In Vitro — 2023 — 2 citations

Conclusion

In conclusion, Dr. Yao Xingwang exemplifies the qualities of a distinguished nurse researcher, clinician, and innovator. His career has been marked by an exceptional combination of hands-on nursing excellence, groundbreaking research contributions, and dedication to improving healthcare outcomes. By bridging clinical nursing with advanced biomedical research, he has advanced patient care in oncology, cardiovascular health, chronic disease management, and mental health interventions. His patents and publications stand as evidence of his innovative spirit and scholarly productivity, while his editorial work reflects a commitment to knowledge dissemination and professional education. Dr. Yao’s leadership in clinical projects, combined with his patient-centered approach, highlights his ability to influence both practice and policy within nursing science. With a proven track record of success and a clear vision for future contributions, he is well-positioned to expand his global collaborations, publish in leading international journals, and assume greater leadership roles in the academic and healthcare communities. Dr. Yao’s achievements and potential make him not only deserving of recognition but also an inspiring role model for the next generation of nursing professionals committed to advancing science and society.

Maria Kourti | Medicine and Dentistry | Best Researcher Award

Prof. Maria Kourti | Medicine and Dentistry | Best Researcher Award

Aristotle University of Thessaloniki | Greece

Prof. Maria Kourti is a distinguished academic and medical professional specializing in Pediatrics with a particular focus on Pediatric Hematology, Oncology, and Infectious Diseases. She currently serves as an Assistant Professor at Aristotle University of Thessaloniki, where she has been deeply involved in both teaching and research. Her career spans over two decades of excellence in clinical practice, scientific research, and international collaborations, with significant contributions to the understanding of childhood leukemia, drug resistance mechanisms, and pediatric infectious diseases. She has authored 73 publications indexed in PubMed, holds an h-index of 16, and has received over 1,000 citations, making her a recognized figure in her field. Prof. Kourti has combined clinical expertise with cutting-edge molecular and proteomic research, actively leading and participating in international multicenter studies and clinical trials. She is also extensively engaged in professional societies at the European and global levels, serving as a board member and committee leader in organizations dedicated to pediatric health. Alongside her academic achievements, she has contributed to medical education, mentorship, and health promotion initiatives, underlining her holistic approach to advancing both science and society. Her distinguished record makes her a highly respected leader in pediatric research and medicine.

Professional Profile

Scopus | ORCID 

Education

Prof. Maria Kourti pursued her entire academic journey at the Aristotle University of Thessaloniki, Greece, one of the most prestigious institutions in the country. She obtained her Medical Degree, laying the foundation for her career in pediatrics. With a strong interest in scientific research, she further advanced her education by earning a Master of Science (MSc) in Medical Research Technology, where she developed early expertise in biomedical investigations. Her passion for oncology and molecular medicine culminated in her Ph.D, with her thesis focused on the “Study of expression of multi-drug resistance genes in pediatric leukemia,” a topic that remains central to her research today. Her commitment to academic and clinical growth did not stop there, as she pursued advanced medical specialization, becoming Board Certified as a Specialist Pediatrician and later recognized as a Pediatric Infectious Disease Specialist. In the same year, she also completed a Post-Doctoral Fellowship in Proteomics in Childhood Leukemia, marking her continued dedication to translational research. This progression highlights her unique integration of medicine and science, equipping her with the academic depth and clinical expertise to make pioneering contributions in pediatric hematology, oncology, and infectious diseases.

Professional Experience

Prof. Maria Kourti has held several critical roles in clinical practice and academia, reflecting her dual expertise as a physician and researcher. she served as an Attending Physician in the Pediatric Oncology Department at Hippokration General Hospital, where she gained extensive clinical experience in treating children with hematological malignancies and solid tumors. Her expertise further deepened during her Pediatric Infectious Disease Fellowship at Aristotle University of Thessaloniki, based at Hippokration General Hospital. she worked as an Attending Physician in the 3rd Department of Pediatrics at Aristotle University, responsible for managing the Pediatric Hematology Unit, demonstrating her leadership in both patient care and academic responsibilities. she was appointed Assistant Professor of Pediatrics–Pediatric Hematology and Oncology at Aristotle University of Thessaloniki, where she continues to combine clinical duties with teaching and high-level research. Her responsibilities extend beyond the university, as she actively participates in national and international research programs, leading initiatives on childhood cancer, supportive care, and clinical trials. Through these roles, Prof. Kourti has developed a reputation for clinical excellence, academic leadership, and research innovation, making her a central figure in pediatric hematology and oncology in Greece and abroad.

Research Interests

Prof. Kourti’s research interests span the intersection of molecular biology, pediatric oncology, and infectious diseases, with a strong emphasis on improving treatment outcomes for children with cancer. Her doctoral and postdoctoral work centered on the molecular mechanisms of drug resistance in childhood leukemia, specifically the expression of multi-drug resistance genes and the application of proteomics to understand disease progression and treatment response. She has also been deeply engaged in genetic polymorphism studies, particularly in metabolic enzymes of carcinogenic substances in patients with acute leukemias and myelodysplastic syndromes. In addition to her oncology work, she has pursued significant research in pediatric infectious diseases, coordinating national efforts for the Greek Supportive Care Group and contributing to clinical research on antifungal therapies and novel antimicrobial strategies. Her interests also extend to large-scale clinical collaborations, where she has been both principal and sub-investigator in 15 multinational clinical trials addressing treatments for pediatric cancers and infections. This breadth of research demonstrates her commitment to translational medicine, bridging laboratory research with clinical applications. Her interests align with global health priorities, focusing on improving survival, reducing treatment toxicity, and enhancing supportive care in children with cancer.

Research Skills

Prof. Kourti possesses a strong foundation in molecular biology and clinical research methodologies, supported by advanced training and decades of practical application. Her technical expertise includes DNA and RNA extraction from blood and bone marrow samples, agarose gel electrophoresis, PCR, and RT-PCR, enabling her to investigate genetic and proteomic markers in pediatric leukemia. She has extensive experience with clinical trial design and implementation, having served as both a principal investigator and sub-investigator in numerous international studies, particularly within the SIOPE and SIOPEN networks. Her skills also extend to multidisciplinary collaboration, coordinating research teams across clinical and laboratory settings. In addition, Prof. Kourti has developed editorial and peer-review skills through her role as Guest Editor of special issues in international journals such as the Journal of Fungi and Diagnostics and as a reviewer for more than 10 medical journals. She also demonstrates expertise in data interpretation, publication writing, and conference presentation, with over 100 oral and poster presentations at national and international congresses. Her combined clinical and laboratory research skills, along with her organizational and editorial experience, make her a versatile and influential contributor to pediatric oncology and infectious disease research worldwide.

Awards and Honors

Throughout her career, Prof. Maria Kourti has received numerous awards and honors recognizing her excellence in research, teaching, and clinical practice. She has earned 10 major distinctions, including 3 scholarships from the National Scholarship Foundation (IKY), awarded for her academic performance and research potential. In addition, she has received 3 educational grants supporting her clinical and research training, as well as 6 first prizes for oral and poster presentations at both national and international medical congresses. These awards highlight not only her dedication to scientific inquiry but also her ability to effectively communicate her findings to diverse audiences. Beyond individual recognition, her leadership roles within professional societies such as the Hellenic Society for Social Pediatrics and Health Promotion, the National Pediatric Hematology and Oncology Society, and participation in European cooperative groups (SIOPE, ESPID, EXPeRT, ESCMID) further demonstrate the esteem in which she is held by the medical and scientific community. She has also contributed as a committee member for sustainability at ESPID, reflecting her commitment to long-term scientific advancement and ethical research practices. These honors collectively underscore her outstanding achievements and her influential role in pediatric medicine and research.

Publication Top Notes

  • Antifungal Use in Immunocompromised Children in Europe: A 12-Week Multicenter Weekly Point Prevalence Survey (CALYPSO) — 2025

  • A Global Analysis of Cases of Mucormycosis Recorded in the ECMM / ISHAM Zygomyco.net Registry from 2009 to 2022 — 2025

  • Medulloblastoma therapy: Consensus treatment recommendations from SIOP-Europe and the European Research Network — 2025 — 3 citations

  • Addressing infectious challenges in pediatric cancer and hematopoietic cell transplantation: insights from the Umbrella Working Group — 2025

  • Invasive Fungal Disease After Chimeric Antigen Receptor-T Immunotherapy in Adult and Pediatric Patients — 2025

  • Planetary Health: What You Need to Know as a Pediatric Infectious Diseases Doctor — 2025

  • Successful Treatment of Disseminated Fusariosis in a 15-Month-old Boy With Refractory Acute Lymphoblastic Leukemia Using High-dose Voriconazole — 2024 — 1 citation

  • Usage of Antifungal Agents in Pediatric Patients Versus Adults: Knowledge and Gaps — 2025

Conclusion

Prof. Maria Kourti exemplifies the qualities of a leading physician-scientist, with a career that integrates clinical expertise, innovative research, and academic leadership. Her groundbreaking work in childhood leukemia, infectious diseases, and pediatric oncology has advanced both scientific knowledge and clinical practice, directly impacting patient outcomes. With more than 73 peer-reviewed publications, extensive participation in international clinical trials, and leadership in national and European research groups, she has established herself as a key figure in the global pediatric research community. Her commitment to mentoring young scientists, active involvement in health promotion initiatives, and editorial contributions further enhance her academic profile. Looking ahead, Prof. Kourti is well-positioned to expand her research into global collaborations, increase her presence in high-impact journals, and take on greater leadership roles in shaping international pediatric oncology policies. Her career trajectory reflects not only past accomplishments but also significant potential for future contributions to medicine, making her a highly deserving candidate for continued recognition. In summary, Prof. Kourti’s lifelong dedication to advancing pediatric care and medical science positions her as an outstanding role model and leader in the field.

Wen Ni | Health Professions | Best Researcher Award

Dr. Wen Ni | Health Professions | Best Researcher Award

Associate Professor from Sun Yat-sen University, China

Dr. Wen Ni is a distinguished academic and researcher currently serving as a Professor at Sun Yat-sen University, China. Her primary research interests lie in the fields of molecular pathology, cancer biology, and translational medicine. With a profound commitment to understanding the mechanisms of disease progression, Dr. Ni has made significant strides in identifying potential biomarkers and therapeutic targets for gastrointestinal and hepatic cancers. Her work is recognized both nationally and internationally, supported by high-impact publications and funded collaborative research projects. Beyond her scientific contributions, she plays an active role in mentoring the next generation of scientists, overseeing graduate students and contributing to institutional research excellence. Dr. Ni’s multi-disciplinary approach, which merges clinical relevance with molecular techniques, continues to drive impactful discoveries. She has also contributed extensively to academic literature, participated in professional societies like ASIP, and served in several advisory and peer-review capacities. Her role as a bridge between research and healthcare reflects her vision for a science-driven, patient-centric future. Dr. Ni remains an influential figure in her domain, representing a strong blend of research leadership, collaborative mindset, and community dedication.

Professional Profile

Education

Dr. Wen Ni pursued her academic training in the biological sciences, culminating in a Ph.D. in Pathology from Sun Yat-sen University. She earned her Bachelor’s degree in Biology from a leading Chinese university, followed by a Master’s degree in Cellular and Molecular Biology. Her doctoral research focused on tumor microenvironment modulation and its implications for hepatocellular carcinoma. This foundational education laid the groundwork for her career in pathology and oncology research. Throughout her academic journey, she has remained engaged in continued professional development, completing advanced training programs and postdoctoral research in specialized fields like translational oncology, immunohistochemistry, and gene expression analysis. Dr. Ni also participated in exchange programs and workshops sponsored by top-tier institutions across Asia and Europe, broadening her scientific perspective and cross-cultural research understanding. Her comprehensive educational background not only equipped her with essential technical expertise but also instilled a drive for interdisciplinary innovation and collaborative research. Today, her educational foundation supports a dynamic research career focused on real-world applications in precision medicine and diagnostic pathology.

Professional Experience

Dr. Wen Ni’s professional experience spans over a decade of academic, clinical, and research-focused roles. She currently holds the position of Professor at Sun Yat-sen University, where she heads a cancer biology lab within the School of Basic Medical Sciences. Her professional journey began as a research assistant in molecular biology, gradually advancing through roles such as Lecturer, Associate Professor, and now full Professor. She has led and co-led multiple national projects funded by the National Natural Science Foundation of China (NSFC), and has served as a key investigator in international research consortia. Apart from research, Dr. Ni has contributed significantly to curriculum development and teaching at both undergraduate and postgraduate levels. Her experience includes organizing academic conferences, leading student research symposia, and serving on the university’s scientific advisory boards. Dr. Ni is also frequently invited to provide expert reviews for peer-reviewed journals and grant funding agencies. Her hands-on involvement in both academic and applied research projects, combined with strategic leadership in institutional planning, reflects a well-rounded professional experience dedicated to scientific advancement and higher education excellence.

Research Interest

Dr. Wen Ni’s research interests lie primarily in the fields of molecular pathology, cancer diagnostics, and translational medicine. Her work centers around understanding the molecular and cellular mechanisms of carcinogenesis, particularly in gastrointestinal and hepatic cancers. She is passionate about decoding tumor heterogeneity, metastasis pathways, and immune microenvironments using advanced bioinformatics, single-cell sequencing, and in vitro/in vivo models. A significant focus of her current research includes the identification of early diagnostic markers and therapeutic targets for liver and colorectal cancers. Dr. Ni also explores epigenetic regulation and non-coding RNAs in tumor progression. Her translational research approach bridges laboratory findings with clinical applications, making her studies relevant for both the bench and the bedside. In addition, she is increasingly integrating artificial intelligence and machine learning in pathological image analysis to support precision oncology. Her future interests involve deeper collaborations in international projects focusing on global cancer epidemiology and therapeutic innovation. Dr. Ni remains committed to pushing boundaries in research that can significantly impact early detection, prognostication, and personalized treatment strategies in cancer care.

Research Skills

Dr. Wen Ni possesses a comprehensive range of research skills that support her advanced work in cancer biology and pathology. Her technical expertise includes molecular cloning, western blotting, PCR, flow cytometry, and CRISPR-Cas9 gene editing. She is proficient in histopathological techniques such as immunohistochemistry (IHC), immunofluorescence, and in situ hybridization, which are critical for tissue-based diagnostics. Dr. Ni also excels in high-throughput sequencing data analysis, including RNA-seq, microarray interpretation, and bioinformatics toolkits like R, SPSS, and Python-based analytics. She has experience handling animal models for tumorigenesis studies and conducting preclinical drug testing in vivo. Moreover, she has led teams in grant writing, project proposal development, and inter-institutional research collaborations. Dr. Ni is also skilled in manuscript preparation, scientific presentation, and academic mentoring. Her ability to integrate experimental and computational biology ensures a holistic approach to scientific inquiry. She emphasizes ethical research practices, lab safety protocols, and robust data management. These multifaceted research skills make her a valuable contributor to multidisciplinary studies and a mentor capable of training emerging scientists for careers in academia and industry.

Awards and Honors

Dr. Wen Ni has received several prestigious awards and honors throughout her academic and research career. She was honored with the Outstanding Young Investigator Award from Sun Yat-sen University for her pioneering work in molecular oncology. Her contributions to cancer diagnostics earned her recognition from the Chinese Society of Pathology, where she was presented with the Excellence in Research Award. She has been a recipient of multiple NSFC research grants, including young scholar support schemes. Internationally, Dr. Ni was selected as a visiting research fellow under the Sino-European Research Exchange Program, facilitating academic exchange with top institutions in Germany and the UK. Her conference presentations at ASIP, AACR, and the International Conference on Molecular Medicine have been well-received, earning her “Best Paper” and “Outstanding Poster” accolades. She has also been nominated to editorial boards of emerging journals in pathology and translational medicine. These awards reflect her continued excellence, innovation, and dedication in advancing scientific knowledge and shaping the next generation of biomedical researchers.

Conclusion

Dr. Wen Ni exemplifies academic excellence, research innovation, and a commitment to societal impact through science. Her leadership in cancer biology research, extensive publications, and international collaborations highlight a career built on quality, relevance, and collaboration. She has significantly contributed to the understanding and application of translational pathology, particularly in developing novel diagnostics and therapeutics. Her influence extends beyond the lab through teaching, mentoring, and involvement in professional scientific communities. Dr. Ni’s profile reflects an ideal candidate for recognition as a top-tier researcher making a global impact. Looking forward, she is poised to lead cross-border research initiatives, contribute to the global fight against cancer, and serve as an inspirational figure for aspiring scientists. Her vision, integrity, and scientific rigor make her an invaluable asset to the research community and a deserving recipient of prestigious international awards.

Farid Badria | Health Professions | Best Researcher Award

Prof. Dr. Farid Badria | Health Professions | Best Researcher Award

Mansoura University, Egypt

Dr. Farid A. Badria is a distinguished Professor of Pharmacognosy at the Faculty of Pharmacy, Mansoura University, Egypt, where he also leads the Liver Research Lab (FAB-Lab). With a career spanning over three decades, he has emerged as a leading expert in natural products research, biomedical sciences, and translational medicine. His research portfolio encompasses phytochemistry, biotechnology, drug discovery, liver diseases, and diagnostic biomarker development. A globally recognized scholar, Dr. Badria’s academic contributions have earned him several prestigious awards, including recognition by Stanford University among the top 2% most-cited scientists in his field. He has held visiting positions at top institutions such as the University of Minnesota and University of Mainz, Germany. His work bridges academia and practical applications by emphasizing sustainable drug development from natural sources, making his research relevant both scientifically and industrially. In addition to his prolific publication record and extensive teaching responsibilities, Dr. Badria has played significant roles in academic governance and research ethics in Egypt. He is a member of multiple scientific organizations and has mentored numerous students and researchers. His commitment to scientific excellence, public health, and academic leadership makes him a worthy contender for the Best Researcher Award.

Professional Profile

Education

Dr. Badria’s educational background reflects his deep expertise in pharmacognosy, cell biology, and natural product chemistry. He holds a Ph.D. in Microbial Transformations and Natural Products Chemistry from the University of Mississippi, USA, where he conducted groundbreaking research on microbial metabolism and structural elucidation of bioactive compounds. Prior to this, he earned a Master of Science in Pharmaceutical Cell Biology and Natural Toxins from the University of Minnesota, USA. His early graduate education also includes an M.Sc. in Pharmacognosy and Natural Products Chemistry from Mansoura University, Egypt, where he began his career as a dedicated researcher. Dr. Badria earned his undergraduate degree, a B.Sc. in Pharmaceutical Sciences, from the same institution. His rigorous academic training in both Egypt and the United States provided him with a comprehensive foundation in natural sciences, advanced analytical techniques, pharmacology, and biotechnology. This diverse and multidisciplinary academic formation has empowered him to investigate complex biomedical problems, develop novel therapeutic strategies, and mentor future generations of scientists in both theoretical and applied pharmaceutical sciences. His global educational experience has also facilitated international collaboration and innovation throughout his career.

Professional Experience

Dr. Farid A. Badria has amassed extensive academic and professional experience, serving in various esteemed roles that have shaped pharmaceutical education and research in Egypt and abroad. At Mansoura University, he has held positions ranging from Assistant Professor (1990) to Full Professor (since 2000), and has served as Head of the Pharmacognosy Department, Head of Applied Drug Research, and Director of the Central Research Lab. As the founding head of the Liver Research Lab (FAB-Lab), he has led pioneering work on liver disorders, natural enzyme modulators, and phytotherapy. His international career includes Visiting Professorships in Medicinal Chemistry at the University of Minnesota (USA) and at Universität Mainz (Germany), where he contributed to research on marine-derived drugs, apoptosis, and biomarkers. He has also served as a consultant and research associate in the United States. Additionally, Dr. Badria has actively contributed to academic governance, including roles on the Supreme Pharmacy Council of Egypt, Clinical Pharmacy Program Committee, and Promotion Committee for Pharmacy Professors. His professional journey reflects a harmonious blend of research innovation, academic leadership, and societal impact. His contributions have not only enriched his institutions but also advanced pharmaceutical sciences at the global level.

Research Interest

Dr. Badria’s research interests are interdisciplinary and pioneering, integrating natural product chemistry, biotechnology, pharmacognosy, and modern therapeutic strategies. His major focus lies in identifying novel bioactive compounds from plants, marine organisms, and microbial sources for use in drug discovery and disease treatment. A core area of his research targets liver diseases, particularly fibrosis and hepatocellular carcinoma, using hepatoselective agents and early diagnostic biomarkers. He is also deeply involved in phytotherapy for skin and metabolic disorders, such as alopecia, hyperpigmentation, obesity, and diabetes, through the modulation of key enzymes like aldose reductase and glucosidase. Additionally, Dr. Badria has worked extensively on cancer diagnostics (particularly ovarian and liver cancer), retinal pathology, and viral infections using both biochemical and AI-based models. His work explores enzyme inhibition as a central therapeutic mechanism and includes studies on topoisomerase, tyrosinase, and hyaluronidase inhibitors. His holistic approach also extends to environmental research, where he has developed biomarkers to monitor marine and freshwater pollution. Overall, Dr. Badria’s research combines traditional natural medicine with cutting-edge biomedical technologies, positioning him at the forefront of translational pharmacognosy and integrative therapeutic sciences.

Research Skills

Dr. Badria possesses a comprehensive and advanced skill set in both laboratory and clinical research methodologies. His expertise in natural products chemistry is demonstrated through his extensive use of chromatographic and spectroscopic techniques (HPLC, NMR, MS, IR, UV) to isolate and characterize novel therapeutic compounds. He is highly skilled in microbial transformation, tissue culture, and biological screening assays for evaluating cytotoxicity, antiviral activity, and enzyme inhibition. His work with mammalian cell culture, tumor induction, cryogenic preservation, and plant tissue cloning reflects his deep command over pharmaceutical biotechnology. Dr. Badria also utilizes AI and computational tools in healthcare research for predictive modeling in liver cancer, obesity, and treatment decision-making. His knowledge of biomarker discovery is applied in both clinical diagnostics and environmental science, identifying indicators for diseases and pollutants in human and aquatic systems. He is adept at experimental design, pharmacological evaluation, and interdisciplinary collaboration. These skills enable him to translate theoretical insights into practical applications, particularly in liver disease therapy, cancer detection, and anti-inflammatory drug development. Dr. Badria’s methodological rigor and technical proficiency are key strengths that drive the success and innovation of his research programs.

Awards and Honors

Dr. Badria’s exceptional research achievements have been recognized with numerous prestigious awards and honors, both nationally and internationally. Most notably, he was cited by Stanford University among the top 2% most-cited scientists in Medicinal and Biomolecular Chemistry. He received the World Intellectual Property Organization (WIPO) Gold Medal in 2011 as the “Best Inventor in Egypt,” and the Third World Academy of Sciences (TWAS) Prize in 2013 for public science communication. His national accolades include multiple State Recognition Awards in Medicine from the Egyptian Academy of Science and Merit of First Class from the President of Egypt in 1998. Internationally, he was honored with the Khawarizmi International Award (Iran, 2000), the NAM S&T Fellowship, and fellowships from UNESCO and the Arab Development Fund. Dr. Badria is also a member of several elite scientific bodies including the American Association for the Advancement of Science (AAAS), New York Academy of Sciences, and the American Society of Pharmacognosy (ASP). These accolades highlight not only his research excellence but also his contributions to science policy, innovation, and knowledge dissemination across borders.

Conclusion

In conclusion, Dr. Farid A. Badria exemplifies the qualities of an outstanding researcher whose work transcends disciplinary boundaries and geographic limitations. His career is characterized by an unwavering commitment to scientific advancement, innovation in natural products research, and impactful contributions to public health, particularly in liver disease treatment and diagnostics. Through his leadership in research, education, and institutional development, he has significantly elevated the scientific standing of Mansoura University and Egypt at large. His global engagements, collaborative initiatives, and mentoring have further amplified the reach and relevance of his work. Dr. Badria’s legacy is built not only on his prolific academic output and technical expertise but also on his dedication to integrating traditional medicine with modern science for the betterment of human health. Given his comprehensive and influential body of work, he is undoubtedly a highly suitable candidate for the Best Researcher Award, representing the highest standards of research integrity, innovation, and social responsibility in the scientific community.

Publications Top Notes

  • Synthesis and biological evaluation of certain α, β-unsaturated ketones and their corresponding fused pyridines as antiviral and cytotoxic agents
    Authors: HI El-Subbagh, SM Abu-Zaid, MA Mahran, FA Badria, AM Al-Obaid
    Journal: Journal of Medicinal Chemistry 43(15), pp. 2915–2921, 2000
    Citations: 536

  • Synthesis and antitumor evaluation of some new 1,3,4-oxadiazole-based heterocycles
    Authors: S Bondock, S Adel, HA Etman, FA Badria
    Journal: European Journal of Medicinal Chemistry 48, pp. 192–199, 2012
    Citations: 266

  • Melatonin, serotonin, and tryptamine in some Egyptian food and medicinal plants
    Author: FA Badria
    Journal: Journal of Medicinal Food 5(3), pp. 153–157, 2002
    Citations: 266

  • Antioxidant and immunomodulatory constituents of henna leaves
    Authors: BR Mikhaeil, FA Badria, GT Maatooq, MMA Amer
    Journal: Zeitschrift für Naturforschung C 59(7–8), pp. 468–476, 2004
    Citations: 265

  • Design and synthesis of azolopyrimidoquinolines, pyrimidoquinazolines as antioxidant, anti-inflammatory and analgesic activities
    Authors: ABA El-Gazzar, MM Youssef, AMS Youssef, AA Abu-Hashem, FA Badria
    Journal: European Journal of Medicinal Chemistry 44(2), pp. 609–624, 2009
    Citations: 236

  • Synthesis, antimicrobial, antioxidant, anti-hemolytic and cytotoxic evaluation of new imidazole-based heterocycles
    Authors: BF Abdel-Wahab, GEA Awad, FA Badria
    Journal: European Journal of Medicinal Chemistry 46(5), pp. 1505–1511, 2011
    Citations: 212

  • Synthesis of some new pyrimido[2′,1′:2,3]thiazolo[4,5-b]quinoxaline derivatives as anti-inflammatory and analgesic agents
    Authors: AA Abu-Hashem, MA Gouda, FA Badria
    Journal: European Journal of Medicinal Chemistry 45(5), pp. 1976–1981, 2010
    Citations: 212

  • Natural products for dental caries prevention
    Authors: FA Badria, OA Zidan
    Journal: Journal of Medicinal Food 7(3), pp. 381–384, 2004
    Citations: 189

  • Chemistry and immunomodulatory activity of frankincense oil
    Authors: BR Mikhaeil, GT Maatooq, FA Badria, MMA Amer
    Journal: Zeitschrift für Naturforschung C 58(3–4), pp. 230–238, 2003
    Citations: 179

  • Immunomodulatory triterpenoids from the oleogum resin of Boswellia carterii Birdwood
    Authors: FA Badria, BR Mikhaeil, GT Maatooq, MMA Amer
    Journal: Zeitschrift für Naturforschung C 58(7–8), pp. 505–516, 2003
    Citations: 165

Zachariah Chowdhury | Medicine and Dentistry | Best Researcher Award

Dr. Zachariah Chowdhury | Medicine and Dentistry | Best Researcher Award

Professor, Dept Of Oncopathology from Mahamana Pandit Madan Mohan Malviya Cancer Centre (Tata Memorial Hospital) Varanasi, India

Dr. Zachariah Chowdhury is an accomplished academician, clinician, and researcher in the field of oncopathology, currently serving as the Professor and Officer-in-Charge of the Department of OncoPathology at the Mahamana Pandit Madan Mohan Malaviya Cancer Centre (MPMMCC) & Homi Bhabha Cancer Hospital (HBCH) in Varanasi, under the Tata Memorial Centre. With foundational training in MBBS and MD in Pathology from Assam Medical College and a UICC Fellowship in Oncopathology, he has demonstrated an unwavering commitment to excellence in pathology and cancer diagnostics. His extensive teaching background includes instruction at multiple academic levels, including DM, MD, MBBS, nursing, and laboratory technology programs. Dr. Chowdhury has amassed an impressive portfolio of over 50 peer-reviewed publications, addressing both common and rare oncological conditions, contributing significantly to the evolving understanding of oncopathology. He is recognized for his comprehensive approach that merges histopathology, cytopathology, hematopathology, and molecular pathology. As a reviewer, invited speaker, and research presenter at both national and international platforms, he exemplifies the qualities of a dedicated and visionary medical researcher. His contributions to both clinical practice and research make him a pivotal figure in the Indian medical community and a strong candidate for national and international honors in the field of cancer pathology.

Professional Profile

Education

Dr. Chowdhury’s academic journey began with outstanding scholastic achievements, securing the 5th rank in his Higher Secondary School Examination from Cotton College, Guwahati, with a remarkable 83.6% score. He earned his MBBS from Assam Medical College under Dibrugarh University in 2004, ranking 2nd in his final examinations. His dedication to medical sciences continued with an MD in Pathology in 2011 from the same institution, where he again demonstrated academic excellence by clearing all examinations in his first attempt. Complementing his postgraduate training, Dr. Chowdhury was awarded the prestigious UICC/Dr. Praful Desai Fellowship in Oncopathology at Tata Memorial Centre, Mumbai, where he further honed his expertise in histopathology, cytopathology, and molecular diagnostics. Additionally, he underwent advanced training in molecular pathology at Tata Medical Centre, Kolkata, and Tata Memorial Centre, Parel, reinforcing his foundation in modern cancer diagnostics. His academic credentials are supported by multiple merit certificates from the Assam Higher Secondary Education Council, All Assam Students Union, and Assam Medical College, highlighting consistent academic distinction from secondary education through to his postgraduate years. This strong educational foundation has enabled Dr. Chowdhury to effectively lead both clinical and academic responsibilities in the field of oncopathology.

Professional Experience

Dr. Zachariah Chowdhury has accumulated rich and diverse professional experience across multiple prestigious institutions. He began his teaching career as a Senior Resident Doctor at the North Eastern Indira Gandhi Regional Institute of Health and Medical Sciences (NEIGRIHMS), Shillong, where he served for three years post-MD, laying a strong foundation in clinical pathology and academic instruction. Currently, he serves as Professor and Officer-in-Charge of the Department of OncoPathology at MPMMCC & HBCH in Varanasi, both units under the Tata Memorial Centre. In this leadership role, he oversees academic training and diagnostic services in a high-volume cancer care setting. Dr. Chowdhury’s responsibilities include teaching DM (OncoPathology), MD (Pathology), MBBS, nursing, and laboratory science students in both theory and laboratory environments. His clinical expertise encompasses a wide spectrum, including histopathology, cytopathology, hematopathology, molecular diagnostics, clinical pathology, renal pathology, immunopathology, and blood banking. Additionally, he plays an active role in quality assurance programs within the diagnostic laboratory. Beyond his hospital commitments, he contributes to academia as a peer reviewer for multiple reputed medical journals and participates in national and international conferences as a speaker, panelist, and faculty. This blend of academic, clinical, and leadership experience underscores his stature as a seasoned medical professional.

Research Interest

Dr. Chowdhury’s research interests center around oncopathology with a multidisciplinary focus that integrates histopathology, molecular pathology, cytopathology, and hematopathology. His scholarly work investigates a wide range of oncological conditions, including breast cancer, thyroid lesions, ovarian tumors, pediatric malignancies, head and neck cancers, and hematolymphoid neoplasms. A key area of his research explores the diagnostic challenges and spectrum of rare tumors such as salivary gland neoplasms, solitary fibrous tumors, and angiosarcomas, with a special emphasis on cytohistological correlations and immunomorphological profiling. Additionally, he has contributed to understanding emerging themes like artificial intelligence in histopathology and the role of molecular diagnostics in rare malignancies. His recent studies include real-world clinical data on metastatic cancers and chemotherapy outcomes, bridging clinical practice with diagnostic research. Dr. Chowdhury’s commitment to evidence-based pathology is evident in his methodical approach to publishing both retrospective reviews and case-based literature, offering valuable insights to the global oncopathology community. His collaborations with multidisciplinary teams from oncology, radiology, and surgery reflect his integrative research philosophy. By focusing on both common diagnostic patterns and rare, underreported entities, his work not only advances academic pathology but also significantly contributes to clinical decision-making and patient outcomes.

Research Skills

Dr. Zachariah Chowdhury brings to the research landscape a comprehensive skill set encompassing classical and modern pathology techniques. He is proficient in histological examination, cytopathological evaluations (including FNAC and core biopsies), hematopathology analyses, and cutting-edge molecular diagnostics. His training at leading cancer centers like Tata Memorial Centre and Tata Medical Centre has equipped him with practical expertise in PCR, FISH, and immunohistochemistry techniques—essential tools in the molecular characterization of tumors. He also has expertise in immunomorphology and has applied these skills across a broad range of clinical cases, from pediatric cancers to high-grade lymphomas and soft tissue tumors. Dr. Chowdhury is also skilled in academic writing and statistical analysis, as evidenced by his extensive publication record across peer-reviewed indexed journals. His systematic approach to clinical audits, retrospective analyses, and diagnostic algorithm development further highlight his research rigor. Additionally, he has contributed to AI applications in cancer diagnosis, showcasing adaptability to new technologies. His experience in organizing research presentations and mentoring junior faculty and students also reflects strong leadership and team management skills within research settings. Altogether, his multidimensional research skills strongly align with the goals of translational oncology and precision medicine.

Awards and Honors

Dr. Chowdhury’s illustrious career has been recognized with numerous awards and honors, validating his significant impact in the field of pathology. Among the most notable are the Bharat Gaurav Puraskar (2023) and the Jewel of India Award (2024), both conferred by the KTK Outstanding Achievers and Education Foundation, New Delhi, for his exemplary contributions to pathology and medical education. During his academic years, he received multiple certificates of merit for academic excellence, including top ranks in both secondary and medical school examinations. His postgraduate performance earned him a Certificate of Merit from Assam Medical College. As a faculty member and researcher, he has consistently excelled in academic events, winning the first prize in Oral Paper Presentation at the 5th International Pediatric Pathology Conference (2022) and the Poster Presentation at NEIGRIHMS Annual Research Day (2018). His early career awards also include the North Eastern Council (NEC) Scholarship for MBBS, which supported his foundational medical education. Beyond these, his recognition extends to being a respected reviewer for multiple journals, and his frequent roles as invited speaker and panelist at various conferences. These accolades reflect both peer and institutional acknowledgment of his enduring impact on medical research and education.

Conclusion

Dr. Zachariah Chowdhury exemplifies the ideals of a clinician-scientist dedicated to excellence in oncopathology. With a firm grounding in both classical pathology and modern diagnostic innovations, he bridges the gap between histological diagnosis and translational cancer research. His career reflects a rare combination of clinical acumen, academic mentorship, research productivity, and institutional leadership. Through his prolific authorship of over 50 peer-reviewed publications, he contributes actively to the global understanding of complex and rare oncological entities. His commitment to education is evident in his multi-level teaching engagements and ongoing mentorship of pathology trainees. Dr. Chowdhury’s recognition through multiple national honors and academic awards further substantiates his role as a leading figure in cancer pathology in India. While already operating at a high level of academic and clinical distinction, future initiatives such as enhanced international collaborations, grant-funded research, and patent development would elevate his profile even further. Overall, Dr. Chowdhury represents a distinguished and highly qualified candidate for any recognition aimed at honoring pathologists and researchers who make substantial contributions to medical science, and particularly, to the evolving discipline of oncopathology.

Publications Top Notes

1. The many faces of ovarian sex cord stromal tumors: a clinicopathological analysis at a tertiary cancer center in North India

  • Year: 2025

  • Authors: Chowdhury Z, Agrawal S, Gupta S, Rai S, Jethani R, Saha S, Ranjan R, Pal A

  • Journal: Surgical and Experimental Pathology

2. The Myriad Spectrum of Salivary Gland Lesions: Cytohistological Correlation on Fine Needle Aspiration Cytology, Core Needle Biopsy, and Resections in a 5-Year Single Institutional Experience of North India

  • Year: 2025

  • Authors: Chowdhury Z, Majumdar P, Narain S, Lamba K

  • Journal: Diagnostic Cytopathology

3. ALK-positive large B-cell lymphoma: A study of six cases from an oncopathology center in North India

  • Year: 2025

  • Authors: Verma A, Chowdhury Z, Singh A, Kant A, Yadav A, Patne SCU

  • Journal: Indian Journal of Pathology and Microbiology

4. Cyto-Histomorphological Analysis of Thyroid Lesions and Risk Assessment of Malignancy/Neoplasia: Insights from a North Indian Tertiary Oncology Center

  • Year: 2025

  • Authors: Haiyat S, Chowdhury Z, Rudra Pal P, Patne S, Dhal I, Paul P

  • Journal: Cureus

5. An Analysis of Pediatric Round Cell Tumors Highlighting the Spectrum of Differential Diagnosis – A Single Center Experience and Systematic Review of Literature

  • Year: 2025

  • Authors: Dhal I, Lali BS, Rai H, Chowdhury Z, Patne S, Tripathi P, Saha S

  • Journal: International Journal of Scientific Studies

6. Real-world data on trastuzumab emtansine (TDM1) efficacy and safety: Results of a single-centre retrospective study of HER2-positive metastatic breast cancer patients

  • Year: 2025

  • Authors: Gupta A, Sansar B, Mishra BK, Khan A, Singh A, Upadhyay A, Chowdhury Z, Patne S, Tripathi M, et al.

  • Journal: Scientific Reports

7. Triple Oral Metronomic Chemotherapy Versus Chemotherapy of Physician Discretion After Failure of Platinum-Based Therapy in Advanced Head and Neck Cancer: A Phase III Randomized Study (METRO-CHASE Study)

  • Year: 2025

  • Authors: Kapoor A, Gupta A, Sansar B, Mishra BK, Gupta P, Singh A, Upadhyay A, Kashyap L, Pal A, Kumar A, Nanda SS, Mukherji A, Kapoor AR, Pradhan S, Mishra A, Chowdhury Z, Patne S, Dhal I, Singh N, et al.

  • Journal: JCO Global Oncology

8. Exploring Solitary Fibrous Tumors at a Tertiary Cancer Center: Clinicopathological and Immunomorphologic Profile

  • Year: 2024

  • Authors: Chowdhury Z, Mishrikotkar S, Nehra P, Patne S, Tripathi M

  • Journal: Cureus

9. A Review of the Applications of Artificial Intelligence in Histopathology

  • Year: 2024

  • Authors: Kandarpa S, Chowdhury Z, Pal PR, Rajput K, Saraf SA

  • Journal: Journal of Cancer Research Reviews & Reports

10. Outcomes of De Novo Oligometastatic Breast Cancer Treated With Surgery of Primary and Metastasis Directed Radiotherapy

  • Year: 2024

  • Authors: Pujari L, Suresh A, Chowdhury Z, Pradhan S, Tripathi M, Gupta A, Singh P, Giridhar P, Kapoor AR, Shinghal A, Sansar B, Mv M

  • Journal: American Journal of Clinical Oncology

 

Nobuhiro Takahashi | Medicine and Dentistry | Best Researcher Award

Dr. Nobuhiro Takahashi | Medicine and Dentistry | Best Researcher Award

Dermatologist from Tokai University School of Medicine, Japan

Dr. Nobuhiro Takahashi is a dedicated clinical professional specializing in dermatology, with a primary focus on inflammatory skin diseases. Currently serving as a Clinical Assistant in the Department of Dermatology at Tokai University Hospital, Kanagawa, Japan, Dr. Takahashi actively participates in both clinical practice and academic training. He has demonstrated a strong commitment to advancing patient care in outpatient dermatology. His work reflects a growing interest in combining clinical insights with research opportunities. With a solid foundation in medical education and practical experience, Dr. Takahashi shows promise for contributing significantly to dermatological research in the future.

Professional Profile

Education

Dr. Nobuhiro Takahashi completed his medical degree at Tokai University School of Medicine, Japan, graduating in March 2020. His academic training provided him with a comprehensive understanding of medical sciences, with a particular interest in dermatology developing during his studies. The rigorous curriculum at Tokai University laid the groundwork for his clinical reasoning, diagnostic skills, and patient management techniques. His education emphasized both theoretical knowledge and practical application, preparing him effectively for postgraduate clinical training and his current clinical role. Dr. Takahashi’s education continues to support his professional development and potential future contributions to clinical research.

Professional Experience

Dr. Takahashi began his professional journey as a Clinical Resident at Tokai University Hospital, where he completed a two-year postgraduate clinical training program from April 2020 to March 2022. This experience allowed him to build strong diagnostic and treatment skills across multiple medical disciplines. Since April 2022, he has been serving as a Clinical Assistant in the Department of Dermatology at Tokai University. In this role, he focuses on outpatient clinical dermatology and academic training, working closely with specialists to manage a variety of dermatological conditions. His current responsibilities allow him to blend clinical service with ongoing professional growth.

Research Interest

Dr. Takahashi’s primary research interests center around dermatology, particularly the study and management of inflammatory skin diseases. He is focused on improving clinical outcomes and advancing therapeutic strategies for these complex skin conditions. His exposure to diverse patient cases in an outpatient setting provides valuable clinical observations that can guide his research direction. While his current profile does not extensively detail research projects or publications, his interest in bridging clinical practice with academic research is evident. Dr. Takahashi is well-positioned to contribute to future dermatological studies that address common and challenging skin disorders.

Research Skills

Dr. Takahashi has developed a strong set of clinical and observational skills through his extensive outpatient dermatology practice. His ability to diagnose, monitor, and manage various skin conditions equips him with firsthand clinical insights essential for relevant and impactful research. Although specific laboratory or advanced research techniques are not detailed in his profile, his clinical experience supports potential development in clinical research methodologies, case study analysis, and patient-centered research. His ongoing academic training is expected to enhance his research capabilities further, enabling him to contribute to clinical trials and evidence-based dermatology studies.

Award and Honors

At this stage of his career, Dr. Takahashi has not yet received formal awards or honors in the field of dermatology or medical research. His professional achievements thus far reflect his dedication to clinical practice and academic growth. As he continues to develop his research portfolio and engage in scholarly activities, there is significant potential for him to earn recognition in the future. Participation in conferences, collaborative research, and contributions to peer-reviewed publications will likely pave the way for future awards and academic honors that acknowledge his efforts in advancing dermatological science.

Conclusion

In conclusion, Dr. Nobuhiro Takahashi is an emerging clinical dermatologist with a promising future in research. His solid educational background, hands-on clinical experience, and keen interest in inflammatory skin diseases demonstrate his dedication to the field. Although he currently has limited research output and formal recognitions, his trajectory indicates potential for future contributions to dermatological science. With continued clinical engagement, research involvement, and academic participation, Dr. Takahashi can develop into a respected researcher who significantly impacts both patient care and dermatological research. His career is well-positioned for continued growth and achievement.

Publication Top Note

  1. Title: A Case of Primary Cutaneous CD8+ Aggressive Epidermotropic Cytotoxic T-Cell Lymphoma
  • Journal: JEADV Clinical Practice
  • Year: 2025